UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 190

Sortiert nach

EP-1422: Contemporary management of bone metastases from breast cancer: Who is getting long course RT?

Radiotherapy and oncology, 2016-04, Vol.119, p.S661-S662

2016

Volltextzugriff (PDF)

Prognostic Models Predicting Survival of Patients with Brain Metastases: Integration of Lactate Dehydrogenase, Albumin and Extracranial Organ Involvement

Clinical oncology (Royal College of Radiologists (Great Britain)), 2014-08, Vol.26 (8), p.447-452

2014

Volltextzugriff (PDF)

627 The Glasgow prognostic score: Inflammatory biomarkers provide useful information when prescribing palliative radiotherapy and selecting an appropriate dose/fractionation regimen

European journal of cancer (1990), 2015-09, Vol.51, p.S124-S125

2015

Volltextzugriff (PDF)

Prediction of Short Survival in Patients with Brain Metastases Based on Three Different Scores: a Role for ‘Triple-negative’ Status?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2010-02, Vol.22 (1), p.65-69

2010

Volltextzugriff (PDF)

A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer

The Journal of urology, 1996-12, Vol.156 (6), p.1934-1941

1996

Volltextzugriff (PDF)

EP-1374: Palliative radiotherapy with or without additional care by a multidisciplinary palliative team (MPT)

Radiotherapy and oncology, 2014, Vol.111, p.S113-S113

2014

Volltextzugriff (PDF)

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients

British journal of cancer, 1997-07, Vol.76 (2), p.238-243

1997

Volltextzugriff (PDF)

Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: A key to study an angiogenic marker in vivo?

Annals of oncology, 1999-08, Vol.10 (8), p.965-971

1999

Volltextzugriff (PDF)

Financial and economic costs of scaling up the provision of HAART to HIV-infected health care workers in KwaZulu-Natal

South African medical journal, 2006-02, Vol.96 (2), p.140-143

2006

Volltextzugriff (PDF)

Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study

European journal of cancer (1990), 2000-01, Vol.36 (2), p.194-199

2000

Volltextzugriff (PDF)

Multisectoral Responses to HIV/AIDS: Applying Research to Policy and Practice

American journal of public health (1971), 2006-07, Vol.96 (7), p.1189-1191

2006

Volltextzugriff (PDF)

A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin

Annals of oncology, 2000-08, Vol.11 (8), p.1035-1040

2000

Volltextzugriff (PDF)

Disease presentation and course in patients with a high number of multiple brain metastases

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.13012-13012

2008

Volltextzugriff (PDF)

Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group

European journal of obstetrics & gynecology and reproductive biology, 1999-10, Vol.86 (2), p.179-183

1999

Volltextzugriff (PDF)

Launching the ARV roll-out debate into the public arena

South African medical journal, 2003-09, Vol.93 (9), p.660-661

2003

Volltextzugriff (PDF)

Estimating the need for palliative external beam radiotherapy in adult cancer patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e20599-e20599

2009

Volltextzugriff (PDF)

The EORTC Phase II study of iproplatin in advanced osteogenic sarcoma

European journal of cancer (1990), 1999-01, Vol.35 (1), p.163-164

1999

Volltextzugriff (PDF)

Does Prophylactic Breast Irradiation in Patients With Prostate Cancer Influence Cardiac Toxicity?

JNCI : Journal of the National Cancer Institute, 2007-11, Vol.99 (21), p.1646-1647

2007

Volltextzugriff (PDF)

Risk-related adjuvant chemotherapy for stage I non-seminoma of the testis

Clinical oncology (Royal College of Radiologists (Great Britain)), 1991-09, Vol.3 (5), p.270-272

1991

Volltextzugriff (PDF)

High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group

European journal of cancer (1990), 1995-09, Vol.31 (10), p.1622-1626

1995

Volltextzugriff (PDF)

An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinoma

European journal of cancer (1990), 1997-03, Vol.33 (3), p.496-499

1997

Volltextzugriff (PDF)

PVB chemotherapy in patients with recurrent or advanced dysgerminoma: A Phase II study of the EORTC Gynaecological Cancer Cooperative Group

Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Vol.10 (5), p.301-305

1998

Volltextzugriff (PDF)

Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: A randomized phase II trial of the EORTC lung cancer cooperative group

Annals of oncology, 1996-08, Vol.7 (6), p.637-639

1996

Volltextzugriff (PDF)

A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis

Seminars in oncology, 1994-10, Vol.21 (5), p.3-6

1994

Volltextzugriff (PDF)

High-dose epirubicin in platinum-pretreated patients with ovarian carcinoma: the EORTC-GCCG experience

European journal of gynaecological oncology, 1995, Vol.16 (6), p.433

1995

Volltextzugriff (PDF)

1 – 25 von 190

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(151)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

EP-1422: Contemporary management of bone metastases from breast cancer: Who is getting long course RT?

Prognostic Models Predicting Survival of Patients with Brain Metastases: Integration of Lactate Dehydrogenase, Albumin and Extracranial Organ Involvement

627 The Glasgow prognostic score: Inflammatory biomarkers provide useful information when prescribing palliative radiotherapy and selecting an appropriate dose/fractionation regimen

Prediction of Short Survival in Patients with Brain Metastases Based on Three Different Scores: a Role for ‘Triple-negative’ Status?

A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer

EP-1374: Palliative radiotherapy with or without additional care by a multidisciplinary palliative team (MPT)

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients

Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: A key to study an angiogenic marker in vivo?

Financial and economic costs of scaling up the provision of HAART to HIV-infected health care workers in KwaZulu-Natal

Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study

Multisectoral Responses to HIV/AIDS: Applying Research to Policy and Practice

A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin

Disease presentation and course in patients with a high number of multiple brain metastases

Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group

Launching the ARV roll-out debate into the public arena

Estimating the need for palliative external beam radiotherapy in adult cancer patients

The EORTC Phase II study of iproplatin in advanced osteogenic sarcoma

Does Prophylactic Breast Irradiation in Patients With Prostate Cancer Influence Cardiac Toxicity?

Risk-related adjuvant chemotherapy for stage I non-seminoma of the testis

High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group

An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinoma

PVB chemotherapy in patients with recurrent or advanced dysgerminoma: A Phase II study of the EORTC Gynaecological Cancer Cooperative Group

Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: A randomized phase II trial of the EORTC lung cancer cooperative group

A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis

High-dose epirubicin in platinum-pretreated patients with ovarian carcinoma: the EORTC-GCCG experience

Suchergebnisse filtern